Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
[Hokkaido Igaku Zasshi] the Hokkaido Journal of Medical Science|December 1, 1987
[Clinical analysis of 82 patients with non-Hodgkin's lymphoma--mainly on the evaluation of therapeutic efficacy]Y Kakinoki, I Maekawa, T Kawamura, et al.
The Tohoku Journal of Experimental Medicine|June 1, 1987
Non-T, non-B acute lymphocytic leukemias: cellular origin based on molecular analyses of immunoglobulin and T-cell alpha- and beta-chain receptor gene rearrangementsM Okabe, S Matsushima, T Fukuhara, et al.
American Journal of Clinical Pathology|January 1, 1991
HTLV-I associated myelopathy (HAM) after blood transfusion in a patient with CD2+ hairy cell leukemiaM Kurosawa, T Machii, T Kitani, et al.
In Vivo (Athens, Greece)|January 1, 1995
Prevalence of human T-cell leukemia virus type 1 (HTLV-I) in family members of adult T-cell leukemia (ATL) patients in non-ATL-endemic Hokkaido of JapanM Iwanaga, S Fujiwara, O Oikawa, et al.
In Vivo (Athens, Greece)|November 1, 1994
Prevalence of human T-cell leukemia virus type 1 (HTLV-I) in adult T-cell leukemia (ATL) in non-ATL-endemic Hokkaido of JapanM Iwanaga, K Takada, S Fujiwara, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 1, 1985
[Phase II study with methyl 6-[3-(2-chloroethyl)-3-nitrosoureido]-6-deoxy-alpha-D-glucopyranoside (MCNU) in hematological malignancies]A Higuchi, T Miyazaki, K Sakurada, et al.
Gastroenterologia Japonica|December 1, 1990
An autopsy case of malignant fibrous histiocytoma of the mediastinum, presenting multiple metastases to the small intestine and to the brain--a rare case report with a review of the literatureJ Misonou, M Kanda, T Shishido, et al.
Leukemia & Lymphoma|January 1, 1994
Establishment and characterization of a new Ph1-positive ALL cell line (ALL/MIK) presenting bcr gene rearrangement on bcr-2 and ALL-type bcr/abl transcript: suggestion of in vitro differentiation to monocytoid lineageT Higa, M Okabe, Y Kunieda, et al.
Leukemia & Lymphoma|November 1, 1995
Administration of rhG-CSF increases complete remission rates after CHOP and ProMACE/CytaBOM for non-Hodgkin's lymphoma: a pilot study. Hokkaido Study Group of Malignant Lymphoma and rhG-CSFM Okabe, I Maekawa, S Suzuki, et al.
Leukemia & Lymphoma|February 1, 1995
Effects of rhG-CSF on infection complications and impaired function of neutrophils secondary to chemotherapy for non-Hodgkin's lymphoma. Hokkaido Study Group of Malignant Lymphoma, and rhG-CSF, JapanY Kuni-Eda, M Okabe, M Kurosawa, et al.
Pageof 5